BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26823679)

  • 1. Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.
    Pantziarka P; Sukhatme V; Bouche G; Meheus L; Sukhatme VP
    Ecancermedicalscience; 2016; 10():610. PubMed ID: 26823679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.
    Pantziarka P; Bouche G; Sukhatme V; Meheus L; Rooman I; Sukhatme VP
    Ecancermedicalscience; 2016; 10():680. PubMed ID: 27899953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.
    Pantziarka P; Sukhatme V; Bouche G; Meheus L; Sukhatme VP
    Ecancermedicalscience; 2015; 9():521. PubMed ID: 25932045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.
    Sukhatme V; Bouche G; Meheus L; Sukhatme VP; Pantziarka P
    Ecancermedicalscience; 2015; 9():568. PubMed ID: 26435741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
    Ecancermedicalscience; 2014; 8():485. PubMed ID: 25525463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
    Klein M
    Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
    Ecancermedicalscience; 2014; 8():443. PubMed ID: 25075217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ReDO_DB: the repurposing drugs in oncology database.
    Pantziarka P; Verbaanderd C; Sukhatme V; Rica Capistrano I; Crispino S; Gyawali B; Rooman I; Van Nuffel AM; Meheus L; Sukhatme VP; Bouche G
    Ecancermedicalscience; 2018; 12():886. PubMed ID: 30679953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment.
    Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A
    Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioremoval of non-steroidal anti-inflammatory drugs by Pseudoxanthomonas sp. DIN-3 isolated from biological activated carbon process.
    Lu Z; Sun W; Li C; Ao X; Yang C; Li S
    Water Res; 2019 Sep; 161():459-472. PubMed ID: 31229727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of in vitro antiovulatory activities of nonsteroidal anti-inflammatory drugs and comparison with in vivo reproductive toxicities of medaka (Oryzias latipes).
    Yokota H; Eguchi S; Hasegawa S; Okada K; Yamamoto F; Sunagawa A; Tanaka M; Yamamoto R; Nakano E
    Environ Toxicol; 2016 Dec; 31(12):1710-1719. PubMed ID: 26183440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of marine mussels to diclofenac: modulation of prostaglandin biosynthesis.
    Courant F; Arpin-Pont L; Bonnefille B; Vacher S; Picot-Groz M; Gomez E; Fenet H
    Environ Sci Pollut Res Int; 2018 Mar; 25(7):6087-6094. PubMed ID: 28528506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical NSAIDs for chronic musculoskeletal pain in adults.
    Derry S; Conaghan P; Da Silva JA; Wiffen PJ; Moore RA
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD007400. PubMed ID: 27103611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention.
    Maniewska J; Jeżewska D
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review.
    Parolini M
    Sci Total Environ; 2020 Oct; 740():140043. PubMed ID: 32559537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision cut intestinal slices are an appropriate ex vivo model to study NSAID-induced intestinal toxicity in rats.
    Niu X; de Graaf IA; van der Bij HA; Groothuis GM
    Toxicol In Vitro; 2014 Oct; 28(7):1296-305. PubMed ID: 25014874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
    Cryer B; Feldman M
    Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Action of Diclofenac with Endotoxin-Mediated Inflammation Exacerbates Intestinal Injury
    Chen WLK; Suter E; Miyazaki H; Velazquez J; Lauffenburger DA; Griffith LG; Carrier RL
    ACS Infect Dis; 2021 Apr; 7(4):838-848. PubMed ID: 33745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective scavenging of intra-mitochondrial superoxide corrects diclofenac-induced mitochondrial dysfunction and gastric injury: A novel gastroprotective mechanism independent of gastric acid suppression.
    Mazumder S; De R; Sarkar S; Siddiqui AA; Saha SJ; Banerjee C; Iqbal MS; Nag S; Debsharma S; Bandyopadhyay U
    Biochem Pharmacol; 2016 Dec; 121():33-51. PubMed ID: 27693316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.